Health
New CRISPR system edits body’s response to prevent immunity against AAVs – Drug Target Review
A CRISPR system that suppresses AAV antibody production has been developed to prevent immunity against the gene therapy.

Posted: 4 September 2020 | Victoria Rees (Drug Target Review) | No comments yet
A novel CRISPR system that suppresses genes related to adeno-associated virus (AAV) antibody production has been developed to prevent immunity against the gene therapy.
Researchers have created a new CRISPR system that suppresses genes related to adeno-associated virus (AAV) antibody production so that the virus can deliver its cargo unimpeded.
According to the researchers from the University of Pittsburgh School…
-
Noosa News23 hours ago
‘Sunny, benign’ school holiday weather after morning showers in parts of Queensland
-
General18 hours ago
Developer warns wind energy capacity may not be ready by WA coal deadline
-
General23 hours ago
Older Aussies back increased superannuation tax
-
Noosa News20 hours ago
Tips to improve engagement – Proctor